Trulimax (Azithromycin ) Non-Interventional Study In Acute Bacterial Upper Respiratory Tract Infections
NCT ID: NCT00827502
Last Updated: 2011-04-28
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
421 participants
OBSERVATIONAL
2009-02-28
2009-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Selection of Antibiotic Resistance by Azithromycin and Clarithromycin in the Oral Flora
NCT00354952
Macrolide Azithromycin to Prevent Rapid Worsening of Symptoms Associated With Chronic Obstructive Pulmonary Disease
NCT00325897
Azithromycin for Patients With Chronic Rhinosinusitis Failing Medical and Surgical Therapy
NCT02307825
Placebo-Controlled Trial of Antibiotic Therapy in Adults With Suspect Lower Respiratory Tract Infection (LRTI) and a Procalcitonin Level
NCT03341273
Study to Measure the Impact of Antibiotics on Bacterial Flora in Adults With Acute Sinusitis
NCT00245440
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with acute URTI, presumed to be of bacterial origin as per the clinical judgment of the investigator.
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pfizer, Inc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pfizer Investigational Site
Jn Vishakhapatnam, Andhra Pradesh, India
Pfizer Investigational Site
Visakhapatnam, Andhra Pradesh, India
Pfizer Investigational Site
Guwhati, Assam, India
Pfizer Investigational Site
Nagpur, Maharashtra, India
Pfizer Investigational Site
Vāshi, Maharashtra, India
Pfizer Investigational Site
New Delhi, National Capital Territory of Delhi, India
Pfizer Investigational Site
New Delhi, National Capital Territory of Delhi, India
Pfizer Investigational Site
Delhi, New Delhi, India
Pfizer Investigational Site
Chennai, Tamil Nadu, India
Pfizer Investigational Site
Chennai, Tamil Nadu, India
Pfizer Investigational Site
Lucknow, Uttar Pradesh, India
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A0661198
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.